Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)

Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)

Saved in:

Bibliographic Details
Main Authors:	Catherine Lai, Minji Lee, Olivia Bobek, Jennifer Le-Rademacher, Sumithra Mandrekar, Gail J. Roboz, Geoffrey L. Uy, Jeanne S. Mandelblatt, Heidi D. Klepin
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Blood Advances
Online Access:	http://www.sciencedirect.com/science/article/pii/S2473952924006839
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Polymorphisms in immunosuppression-related genes are associated with AML
by: Mingying Li, et al.
Published: (2025-02-01)

Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
by: Mirazul Islam, et al.
Published: (2017-01-01)

Not All Beef Marketing Alliances Are the Same: A Review of Alliance Types
by: Thomas E. Anton
Published: (2002-11-01)

Not All Beef Marketing Alliances Are the Same: A Review of Alliance Types
by: Thomas E. Anton
Published: (2002-11-01)

STRATEGIC ALLIANCES AND PARTNERSHIPS
by: S. Vasilenko
Published: (2016-11-01)

Global applications of the frailty index based on the deficit accumulation model
by: Xuemei Cai, et al.
Published: (2025-01-01)

Acute Myeloid Leukemia (AML) Detection Using AlexNet Model
by: Maneela Shaheen, et al.
Published: (2021-01-01)

Does the regional use of intensive chemotherapy impact the outcome of adults with AML?
by: Corentin Orvain
Published: (2024-12-01)

Evolving racial/ethnic disparities in AML survival in the novel therapy era
by: Xin Wang, et al.
Published: (2025-02-01)

Pitfalls in Diagnosis: JMML versus KMT2A Rearranged Juvenile AML
by: Liesbeth Vanheeswijck, et al.
Published: (2024-01-01)

G-CSF-Associated Bone Marrow Necrosis in AML after Induction Chemotherapy
by: Ikenna Osuorji, et al.
Published: (2012-01-01)

Long-Term Use of Ruxolitinib in an AML Patient with Posttransplant Steroid Refractory GVHD
by: Philip T. Sobash, et al.
Published: (2020-01-01)

Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival?
by: Hester F Lingsma, et al.
Published: (2024-07-01)

Frailty: an emerging geriatric syndrome
by: Ángel Julio Romero Carbrera
Published: (2010-12-01)

Frailty in older adults admitted to hospital: outcomes from the Western Sydney Clinical Frailty Registry
by: Julee McDonagh, et al.
Published: (2025-02-01)

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML
by: Patrick Schlegel, et al.
Published: (2015-01-01)

Granulocytic Sarcoma of the Uterus: A Rare Presentation of Extramedullary Relapse of AML and Importance of MRI
by: Murat Ucar, et al.
Published: (2014-01-01)

Inhibition of NLRP3 enhances pro-apoptotic effects of FLT3 inhibition in AML
by: Helene Sieberer, et al.
Published: (2025-01-01)

The World's Evangelical Alliance and the Spanish Civil War
by: F Hale
Published: (2000-12-01)

Beef Alliances: A Basic Economic Overview
by: Thomas E. Anton
Published: (2002-07-01)

Beef Alliances: A Basic Economic Overview
by: Thomas E. Anton
Published: (2002-07-01)

L’essence de l’alliance religieuse
by: Gregory Delaplace
Published: (2023-06-01)

An Electronic Frailty Index Based on Deficit Accumulation May Predict Glaucomatous Visual Field Progression
by: Duy W, et al.
Published: (2025-02-01)

Reversibility of Frailty after Lung Transplantation
by: Elyn Montgomery, et al.
Published: (2020-01-01)

Frailty in Older Adults and Physical Activity
by: Jorge Luis Abreus Mora, et al.
Published: (2023-03-01)

Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives
by: Zahra Khosroabadi, et al.
Published: (2025-01-01)

Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
by: Naveed Ali, et al.
Published: (2025-02-01)

Corrigendum to “The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes”
by: Nicola Napoli, et al.
Published: (2017-01-01)

Merger syndrome: impacts on people in a strategic alliance
by: Sabrina Romero de Oliveira Montenegro
Published: (2017-05-01)

Association of social frailty, sarcopenia, and oral frailty with depressive symptoms in Chinese older adults: a cross-sectional study
by: Yuanhao Sun, et al.
Published: (2025-02-01)

A novel perspective on survival prediction for AML patients: Integration of machine learning in SEER database applications
by: Zheng-yi Jia, et al.
Published: (2025-01-01)

Caspase 3-specific cleavage of ubiquitin-specific peptidase 48 enhances drug-induced apoptosis in AML
by: Zhanglin Zhang, et al.
Published: (2025-12-01)

Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML
by: Julia M. Unglaub, et al.
Published: (2025-01-01)

Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Maria I. Zervou, et al.
Published: (2025-02-01)

Associations of cachexia and frailty with amyotrophic lateral sclerosis
by: Tracy L. Peters, et al.
Published: (2025-02-01)

Human rights and neoliberalism: an uneasy alliance for protecting children in Mexico
by: Anahely Medrano Buenrostro
Published: (2011-01-01)

The strategic alliance of higher education institutions: Experience of contemporary Germany
by: A. M. Petrov
Published: (2021-04-01)

Cooperative Carbon Alliances: Defining an Agenda for Global Industrial Decarbonisation
by: Aylin Shawkat, et al.
Published: (2022-06-01)

Changing role of security alliances in the post-Cold War era
by: I. A. Istomin, et al.
Published: (2024-07-01)

Public-Private Partnership: High-Impact Alliance for Sustainability Targets
by: Y. I. Vaslavskiy
Published: (2022-11-01)